Sulfamide

Sulfamide

SCHEMBL3293102

NS(N)(=O)=O.[N]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamide SCHEMBL5880 0.93
Sulfamide SCHEMBL10866317 0.86
Sulfamide SCHEMBL1000467 0.86
Sulfamide SCHEMBL3827754 0.86
Sulfamide SCHEMBL10866319 0.86
Sulfamide SCHEMBL17495597 0.86
Sulfamide SCHEMBL5067852 0.86
Sulfamide SCHEMBL5667325 0.86
Sulfamide SCHEMBL3409127 0.86
Sulfamide SCHEMBL29808726 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4211146-B1 SYNTHETIC CYCLIC PEPTIDE MIMETICS UNIV BAR ILAN (IL) 2026-05-20 EP disclosed
US-12616760-B2 Synthetic cyclic peptide mimetics BAR ILAN UNIVERSITY (IL) 2026-05-05 US disclosed
US-20240316225-A1 SYNTHETIC CYCLIC PEPTIDE MIMETICS BAR ILAN UNIVERSITY (IL) 2024-09-26 US disclosed
US-20240294548-A1 TRICYCLIC SULTAMS AND SULFAMIDES AS ANTITUMOR AGENTS PELOTON THERAPEUTICS INC. 2024-09-05 US disclosed
EP-4387610-A1 TRICYCLIC SULTAMS AND SULFAMIDES AS ANTITUMOR AGENTS Peloton Therapeutics, Inc. (US) 2024-06-26 EP disclosed
WO-2023064058-A1 TRICYCLIC SULTAMS AND SULFAMIDES AS ANTITUMOR AGENTS PELOTON THERAPEUTICS INC. (US) 2023-04-20 WO disclosed
CN-103657513-B Gemini-type ampholytic surfactant based on perfluoroolefine and preparation method thereof UNIV QUZHOU 2015-06-17 CN disclosed
CN-103657513-A Gemini-type ampholytic surfactant based on perfluoroolefine and preparation method thereof UNIV QUZHOU 2014-03-26 CN disclosed
US-7718652-B2 Substituted benzothiadiazinedioxide derivatives and methods of their use WYETH LLC (US) 2010-05-18 US disclosed
US-20080161295-A1 SUBSTITUTED BENZOTHIADIAZINEDIOXIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-07-03 US disclosed
WO-2008073958-A2 SUBSTITUTED BENZOTHIADIAZINEDIOXIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO disclosed
US-4044151-A Sulfamidophenethanolamine therapeutic process MEAD JOHNSON & COMPANY (US) 1977-08-23 US disclosed